The PTA balloon catheter market was USD 2,231.6 million in 2022, which is likely to touch USD 4,591.2 million, propelling at a 9.4% compound annual growth rate, by 2030.
The growth of this industry is mainly because of the rising occurrence of obesity and CVDs, increasing tobacco consumption, and the surging count of minimally invasive surgical processes.
In 2022, the nylon category, based on material type, was the largest contributor to the industry. This is primarily because nylon catheters are scratch-resistant and have greater patient compliance.
North America was the largest contributor to the industry in 2022, with approximately 35% share. For many years, CVDs have been a key cause of mortality in the U.S. According to the CDC, in 2021, 0.69 million individuals in the U.S. died of heart ailments, with over one demise each minute.
APAC is advancing at the fastest rate, primarily due to the surging occurrence of problems associated with the heart as well as the mounting elderly populace. Moreover, the most common heart ailments in India are coronary artery disease, cardiomyopathy, rheumatic heart disease, cerebrovascular disease, valvular heart disease, heart failure, and heart attack.
Furthermore, factors like economic advancement as well as the increasing healthcare spending will further boost the growth of the regional industry.
With the mounting incidence of CVDs and obesity coupled with increasing tobacco usage, the PTA balloon catheter industry will continue to progress in the years to come.